CaptivateIQ reports that while 59% of companies rely on incentives for growth, many fail to execute them effectively, ...
On January 7, 2026, the Trump administration issued Executive Order 14372 entitled “Prioritizing the Warfighter in Defense ...
Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results